We are live on
!
Find out more
ORIAW
Orion Biotech Opportunities Corp. Warrant
ORIAW
ORIAW
Delisted
ORIAW was delisted on the 28th of April, 2023.
25 hedge funds and large institutions have $648K invested in Orion Biotech Opportunities Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% less funds holding
Funds holding: 29 → 25 (-4)
71% less capital invested
Capital invested by funds: $2.25M → $648K (-$1.6M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Holders
25
Holders Change
-4
Holders Change %
-13.79%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
5
Closed
3
Calls
$1.18M
Puts
–
Net Calls
+$1.18M
Net Calls Change
+$615K
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
AGC
Angelo Gordon & Co
New York
|
-$15.7K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$4.18K |
| 3 |
SC
Sculptor Capital
New York
|
-$3.17K |
| 4 |
FIG
Fortress Investment Group
New York
|
-$2.86K |
| 5 |
GAM
Gritstone Asset Management
Bethesda,
Maryland
|
-$2.16K |